The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Editorial
PreviousPrevious
Volume 338:1221-1222 April 23, 1998 Number 17
NextNext

Primary Venous Thromboembolism and Cancer Screening

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Sørensen, H. T.
-PubMed Citation
For more than a century we have known that deep venous thrombosis or pulmonary embolism may be the presenting feature of an occult cancer. The association between venous thromboembolism and cancer raises three questions: What is the mechanism, how strong is the association, and what are the implications for patient care?

The mechanisms of cancer-induced venous thrombosis have been widely studied, mainly in patients with overt cancers. These mechanisms include invasion of cancer cells into the vessel wall, compression of the vasculature by a tumor, and hypercoagulability induced by the cancer. Studies of patients with solid tumors or leukemia using . . . [Full Text of this Article]

References


This article has been cited by other articles:



HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  TERMS OF USE  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved.